P. Böhlen

发表

Immunoreactive and biologically active growth hormone-releasing factor in the rat placenta.

N. Ling, A. Baird, W. B. Wehrenberg, 1985, Endocrinology.

Biological Activity and Mechanisms of Action of Somatocrinin, Growth Hormone Releasing Factor, on the Release of Growth Hormone in Vitro and its Antagonism by Somatostatin

N. Ling, R. Guillemin, S. Ying, 1984 .

Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly.

N. Ling, R. Guillemin, W. B. Wehrenberg, 1982, Science.

THE EFFECT OF 4‐AMINO HEX‐5‐YNOIC ACID (γ‐ACETYLENIC GABA, γ‐ETHYNYL GABA) A CATALYTIC INHIBITOR OF GABA TRANSAMINASE, ON BRAIN GABA METABOLISM IN VIVO

A. Sjoerdsma, P. Schechter, B. Metcalf, 1977 .

γ‐VINYL GABA (4‐amino‐hex‐5‐enoic acid), A NEW SELECTIVE IRREVERSIBLE INHIBITOR OF GABA‐T: EFFECTS ON BRAIN GABA METABOLISM IN MICE 1

P. Schechter, B. Metcalf, P. Böhlen, 1977, Journal of neurochemistry.

A method for the unambiguous identification of tryptophan in automated protein sequence analysis.

P. Böhlen, T. Müller-Michel, 1990, Analytical biochemistry.

Immunoreactive fibroblast growth factor in cells of peritoneal exudate suggests its identity with macrophage-derived growth factor.

P. Morméde, A. Baird, P. Böhlen, 1985, Biochemical and biophysical research communications.

Isolation of pituitary fibroblast growth factor by fast protein liquid chromatography (FPLC): Partial chemical and biological characterization

D. Gospodarowicz, G. Lui, P. Böhlen, 1985, Journal of cellular physiology.

Inhibition of the pulsatile secretion of growth hormone by monoclonal antibodies to the hypothalamic growth hormone releasing factor (GRF).

R. Guillemin, W. B. Wehrenberg, P. Böhlen, 1982, Endocrinology.

Molecular characterization of fibroblast growth factor: distribution and biological activities in various tissues.

N. Ling, R. Guillemin, N. Ueno, 1986, Recent progress in hormone research.

Somatocrinin, the growth hormone releasing factor.

N. Ling, R. Guillemin, B. Bloch, 1984, Recent progress in hormone research.

Growth hormone releasing factor, somatocrinin, releases pituitary growth hormone in vitro.

N. Ling, R. Guillemin, S. Ying, 1982, Proceedings of the National Academy of Sciences of the United States of America.

Human hypothalamic growth hormone releasing factor (GRF): evidence for two forms identical to tumor derived GRF-44-NH2 and GRF-40.

N. Ling, R. Guillemin, B. Bloch, 1983, Biochemical and biophysical research communications.

A simplified protein assay with fluorescamine in samples containing interfering material.

S. Udenfriend, K. Imai, P. Böhlen, 1974, Analytical biochemistry.

Inhibitory action of transforming growth factor beta on endothelial cells.

W. Birchmeier, G. Müller, J. Behrens, 1987, Proceedings of the National Academy of Sciences of the United States of America.

Biological activity and phosphorylation sites of the bacterially expressed cytosolic domain of the KDR VEGF-receptor.

B. Terman, P. Böhlen, J. Hulmes, 1994, Biochemical and biophysical research communications.

Endothelial cell growth factors in embryonic and adult chick brain are related to human acidic fibroblast growth factor.

W. Risau, P. Böhlen, P. Gautschi-Sova, 1988, The EMBO journal.

Amino-terminal sequences of a novel heparin-binding protein from human, bovine, rat, and chick brain: High interspecies homology

P. Böhlen, D. Huber, P. Gautschi-Sova, 1990, Neurochemical Research.

Properly oriented heparin-decasaccharide-induced dimers are the biologically active form of basic fibroblast growth factor.

R. Powers, D. Kitchen, F. Moy, 1997, Biochemistry.

Diminished heparin binding of a basic fibroblast growth factor mutant is associated with reduced receptor binding, mitogenesis, plasminogen activator induction, and in vitro angiogenesis.

A. Yayon, D. Aviezer, M. Safran, 1994, Biochemistry.

Structure of the gene coding for the human retinoic acid-inducible factor, MK.

E. Kovács, I. Kovesdi, P. Kretschmer, 1993, DNA and cell biology.

Growth hormone releasing factors.

N. Ling, R. Guillemin, A. Baird, 1985, Annual review of biochemistry.

Isolation and characterization of a γ1‐melanotropin‐like peptide from bovine neurointermediate pituitary

N. Ling, R. Guillemin, P. Böhlen, 1981, FEBS letters.

Cloning and sequence analysis of cDNA for the precursor of human growth hormone-releasing factor, somatocrinin.

N. Ling, P. Lomedico, B. Hoffman, 1983, Proceedings of the National Academy of Sciences of the United States of America.

A glycosylation-deficient endothelial cell mutant with modified responses to transforming growth factor-beta and other growth inhibitory cytokines: evidence for multiple growth inhibitory signal transduction pathways.

B. O'hara, V. Fafeur, P. Böhlen, 1993, Molecular biology of the cell.

Amino acid analysis with fluorescamine at the picomole level.

S. Udenfriend, W. Dairman, P. Böhlen, 1973, Archives of biochemistry and biophysics.

Automatic Monitoring of primary amines in preparative column effluents with fluorescamine.

S. Udenfriend, P. Böhlen, S. Stein, 1975, Analytical biochemistry.

Acidic fibroblast growth factor is present in nonneural tissue: isolation and chemical characterization from bovine kidney.

P. Böhlen, M. Fràter-schröder, P. Gautschi-Sova, 1987, Biochemistry.

Isolation and partial molecular characterization of pituitary fibroblast growth factor.

N. Ling, D. Gospodarowicz, A. Baird, 1984, Proceedings of the National Academy of Sciences of the United States of America.

Human brain fibroblast growth factor

D. Gospodarowicz, K. Jones, A. Baird, 1985, FEBS letters.

Purification of kidney epithelial cell growth inhibitors.

R. W. Holley, P. Böhlen, R. Fava, 1980, Proceedings of the National Academy of Sciences of the United States of America.

High biological activity of the synthetic replicates of somatostatin-28 and somatostatin-25

N. Ling, R. Guillemin, P. Böhlen, 1981, Regulatory Peptides.

High-sensitivity amino acid analysis: methodology for the determination of amino acid compositions with less than 100 picomoles of peptides.

R. Schroeder, P. Böhlen, 1982, Analytical biochemistry.

Isolation and characterization of the porcine hypothalamic growth hormone releasing factor.

N. Ling, R. Guillemin, P. Böhlen, 1983, Biochemical and biophysical research communications.

Isolation and sequence of rat peptide YY and neuropeptide Y

P. Böhlen, R. Gaillard, R. Corder, 1988, Regulatory Peptides.

The relationship between GABA concentrations in brain and cerebrospinal fluid

M. Palfreyman, P. Böhlen, S. Huot, 1979, Brain Research.

Isolation and characterization of rat pancreatic somatostatin.

N. Ling, R. Guillemin, P. Böhlen, 1980, Endocrinology.

The mitogenic activity of insulin: an intrinsic property of the molecule.

P. Petrides, P. Böhlen, 1980, Biochemical and biophysical research communications.

Presence of somatostatin-28-(1-12) in hypothalamus and pancreas.

N. Ling, R. Guillemin, S. Ying, 1982, Proceedings of the National Academy of Sciences of the United States of America.

Primary structure of ovine hypothalamic somatostatin-28 and somatostatin-25.

N. Ling, R. Guillemin, P. Böhlen, 1980, Proceedings of the National Academy of Sciences of the United States of America.

Two distinct mechanisms for ornithine decarboxylase regulation by polyamines in rat hepatoma cells

P. McCann, C. Tardif, P. Böhlen, 1979, Journal of cellular physiology.

A male accessory gland peptide with protease inhibitory activity in Drosophila funebris.

P. S. Chen, S. Stone, P. Böhlen, 1989, The Journal of biological chemistry.

Somatocrinin, growth hormone releasing factor, stimulates secretion of growth hormone in anesthetized rats.

N. Ling, R. Guillemin, S. Ying, 1982, Biochemical and biophysical research communications.

Characterization of a 40 residue peptide from a human pancreatic tumor with growth hormone releasing activity.

N. Ling, R. Guillemin, M. Thorner, 1982, Biochemical and biophysical research communications.

Treatment of Huntington disease with gamma-acetylenic GABA an irreversible inhibitor of GABA-transaminase: increased CSF GABA and homocarnosine without clinical amelioration.

Y. Agid, A. Bonnet, G. Chazot, 1981, Neurology.

Isolation from bovine brain and structural characterization of HBNF, a heparin-binding neurotrophic factor.

C. Rasool, I. Kovesdi, P. Kretschmer, 1991, Growth factors.

Fibroblast growth factor in the human placenta.

D. Gospodarowicz, G. Lui, A. Baird, 1985, Biochemical and biophysical research communications.

Somatocrinin (growth hormone releasing factor) in vitro bioactivity; Ca++ involvement, cAMP mediated action and additivity of effect with PGE2.

N. Ling, R. Guillemin, C. Mougin, 1982, Biochemical and biophysical research communications.

Alpha-methyl ornithine, a potent competitive inhibitor of ornithine decarboxylase, blocks proliferation of rat hepatoma cells in culture.

P. McCann, C. Tardif, F. Schuber, 1976, Proceedings of the National Academy of Sciences of the United States of America.

Inactivation of the bovine mitochondrial F1-ATPase with dicyclohexyl[14C]carbodiimide leads to the modification of a specific glutamic acid residue in the beta subunit.

M. Yoshida, W. Allison, P. Böhlen, 1981, The Journal of biological chemistry.

Isolation, primary structure, and synthesis of human hypothalamic somatocrinin: growth hormone-releasing factor.

N. Ling, R. Guillemin, W. B. Wehrenberg, 1984, Proceedings of the National Academy of Sciences of the United States of America.

Human growth hormone releasing factor and somatostatin from two pancreatic tumors: isolation and characterization

N. Ling, R. Guillemin, W. B. Wehrenberg, 1983, Regulatory Peptides.

Microisolation of neuropeptides.

N. Ling, P. Böhlen, F. Esch, 1983, Methods in enzymology.

Monoclonal antibodies to hypothalamic growth hormone-releasing factor with picomoles of antigen.

R. Guillemin, P. Böhlen, P. Brazeau, 1982, Science.

Isolation and chemical characterization of somatostatin-28 from rat hypothalamus

N. Ling, R. Guillemin, P. Böhlen, 1981, Regulatory Peptides.

Cerebrospinal fluid homocarnosine in Huntington's disease.

Y. Agid, G. Chazot, P. Schechter, 1980, Life sciences.

Preliminary X-ray crystallographic analysis of a modified basic fibroblast growth factor.

C. Schutt, D. Bollag, Y. Gluzman, 1991, Journal of molecular biology.

Anti-viral activity of human recombinant heparin-binding proteins HBNF and MK.

J. Backer, M. Ostrander, P. Böhlen, 1992, Biochemical and biophysical research communications.

Immunoreactive fibroblast growth factor (FGF) in a transplantable chondrosarcoma: Inhibition of tumor growth by antibodies to FGF

A. Baird, P. Böhlen, P. Mormède, 1986, Journal of cellular biochemistry.

Isolation and partial characterization of an endothelial cell growth factor from the bovine kidney: homology with basic fibroblast growth factor

N. Ling, D. Gospodarowicz, A. Baird, 1985, Regulatory Peptides.

Isolation and amino acid composition of two somatostatin-like peptides from ovine hypothalamus: somatostatin-28 and somatostatin-25.

N. Ling, R. Guillemin, P. Böhlen, 1980, Biochemical and biophysical research communications.

Audiogenic seizure protection by elevated brain GABA concentration in mice: Effects of γ-acetylenic GABA and γ-vinyl GABA, two irreversible GABA-T inhibitors

P. Schechter, P. Böhlen, M. Jung, 1977 .

Studies on the reaction of fluorescamine with primary amines.

S. Udenfriend, W. Leimgruber, M. Weigele, 1974, Archives of biochemistry and biophysics.

Physiological studies with somatocrinin, a growth hormone-releasing factor.

N. Ling, R. Guillemin, S. Ying, 1985, Annual review of pharmacology and toxicology.

Signal transduction by bFGF, but not TGFβ1, involves arachidonic acid metabolism in endothelial cells

V. Fafeur, P. Böhlen, Zhi-Ping Jiang, 1991, Journal of cellular physiology.

Comparison of radioimmunoassay, chemical assay (HPLC) and bioassay for arginine vasopressin in synthetic standards and posterior pituitary tissue.

V. Pliska, P. Böhlen, J. Möhring, 1982, Acta endocrinologica.

Primary structure of PDC-109, a major protein constituent of bovine seminal plasma.

N. Ling, R. Guillemin, S. Ying, 1983, Biochemical and biophysical research communications.

Purification and N-terminal amino acid sequence of the human T90/44 (CD28) antigen

W. Lesslauer, P. Böhlen, H. Gmünder, 2004, Immunogenetics.

Physiological roles of somatocrinin and somatostatin in the regulation of growth hormone secretion.

N. Ling, R. Guillemin, W. B. Wehrenberg, 1982, Biochemical and biophysical research communications.

Neuropeptides derived from prosomatostatin that do not contain the somatostatin-14 sequence

N. Ling, P. Böhlen, F. Esch, 1984, Brain Research.

Isolation and structure of a novel C-terminally amidated opioid peptide, amidorphin, from bovine adrenal medulla

B. Seizinger, C. Evans, A. Herz, 1985, Nature.

Audiogenic seizure protection by elevated brain GABA concentration in mice: effects of gamma-acetylenic gaba and gamma-vinyl GABA, two irreversible GABA-T inhibitors.

P. Schechter, P. Böhlen, M. Jung, 1977, European journal of pharmacology.

Metorphamide: isolation, structure, and biologic activity of an amidated opioid octapeptide from bovine brain.

C. Evans, J. Barchas, A. McKnight, 1983, Proceedings of the National Academy of Sciences of the United States of America.

Isolation and characterization of the bovine hypothalamic growth hormone releasing factor.

N. Ling, R. Guillemin, P. Böhlen, 1983, Biochemical and biophysical research communications.

Automated fluorometric amino acid analysis: the determination of proline and hydroxyproline.

P. Böhlen, M. Mellet, 1979, Analytical biochemistry.

Purification from Brain of Synenkephalin, the N‐Terminal Fragment of Proenkephalin

J. Rossier, P. Böhlen, Dane Listen, 1984, Journal of neurochemistry.

Purification of the N-terminal fragment of proenkephalin from bovine adrenal medulla.

J. Rossier, P. Chabrier, P. Böhlen, 1983, Life sciences.

Molecular forms of the putative enkephalin precursor BAM-12P in bovine adrenal, pituitary, and hypothalamus.

N. Ling, R. Guillemin, A. Baird, 1982, Proceedings of the National Academy of Sciences of the United States of America.

Purification of platelet-derived endothelial cell growth inhibitor and its characterization as transforming growth factor-β type 1

P. Böhlen, Stefanie Magyar‐Lehmann, 1992, Experientia.

Chemical characterization of the two forms of epidermal growth factor in murine saliva.

J. Shively, P. Petrides, P. Böhlen, 1984, Biochemical and biophysical research communications.

Automated assay of gamma-aminobutyric acid in human cerebrospinal fluid.

P. Schechter, J. Dosch, J. Koch-weser, 1978, Clinical chemistry.

Fluorometric assay of proteins in the nanogram range.

S. Udenfriend, S. Stein, W. Dairman, 1973, Archives of biochemistry and biophysics.

Different molecular forms of basic fibroblast growth factor (bFGF) accelerate duodenal ulcer healing in rats.

S. Szabó, S. Kusstatscher, P. Böhlen, 1995, The Journal of pharmacology and experimental therapeutics.

Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF.

N. Ling, R. Guillemin, D. Gospodarowicz, 1985, Proceedings of the National Academy of Sciences of the United States of America.

Acidic fibroblast growth factor (FGF) from bovine brain: amino‐terminal sequence and comparison with basic FGF.

D. Gospodarowicz, A. Baird, P. Böhlen, 1985, The EMBO journal.

Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor.

D. Dimitrov, D. Gospodarowicz, B. Terman, 1992, Biochemical and biophysical research communications.

Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo.

W. Risau, P. Böhlen, R. Hallmann, 1987, Proceedings of the National Academy of Sciences of the United States of America.

Studies on the kinetics of reaction and hydrolysis of fluorescamine.

S Udenfriend, S. Udenfriend, P Böhlen, 1974, Archives of biochemistry and biophysics.

Detection of fluorescamine-labeled amino acids, peptides, and other primary amines on thin-layer chromatograms

S. Udenfriend, K. Imai, S. Stein, 1974 .

Distinct tissue specific mitochondrial creatine kinases from chicken brain and striated muscle with a conserved CK framework.

M. Wyss, H. Eppenberger, T. Wallimann, 1988, Biochemical and biophysical research communications.

Cloning, characterization and developmental regulation of two members of a novel human gene family of neurite outgrowth-promoting proteins.

I. Kovesdi, Y. Gluzman, P. Kretschmer, 1991, Growth factors.

HBNF and MK, members of a novel gene family of heparin-binding proteins with potential roles in embryogenesis and brain function.

I. Kovesdi, P. Böhlen, 1991, Progress in growth factor research.

Isolation and partial characterization of human T-cell growth factor.

G. Dennert, P. Böhlen, F. Esch, 1983, Biochemical and biophysical research communications.

Acidic fibroblast growth factor (aFGF) is present in the fluid of brain tumour pseudocysts

J. Moringlane, P. Böhlen, R. Spinas, 2005, Acta Neurochirurgica.

Heparin-binding neurotrophic factor (HBNF) and MK, members of a new family of homologous, developmentally regulated proteins.

I. Kovesdi, P. Kretschmer, J. Fairhurst, 1990, Biochemical and biophysical research communications.

A male accessory gland peptide that regulates reproductive behavior of female D. melanogaster

M. Bienz, T. Aigaki, P. S. Chen, 1988, Cell.

Expression of the HBNF (heparin-binding neurite-promoting factor) gene in the brain of fetal, neonatal and adult rat: an in situ hybridization study.

B. Bloch, E. Normand, I. Kovesdi, 1992, Brain research. Developmental brain research.

Uptake and distribution of hexane in rat tissues.

P. Böhlen, U. Schlunegger, E. Läuppi, 1973, Toxicology and applied pharmacology.

Analytical and preparative mapping of complex peptide mixtures reversed-phase high-performance liquid chromatography

P. Böhlen, G. Kleeman, 1981 .

VEGF receptor subtypes KDR and FLT1 show different sensitivities to heparin and placenta growth factor.

D. Gospodarowicz, N. Lassam, M. Persico, 1994, Growth factors.

Transforming growth factor-beta inhibits endothelial cell proliferation.

W. Birchmeier, G. Müller, P. Böhlen, 1986, Biochemical and biophysical research communications.

Amino acid analysis with fluorescamine of stained protein bands from polyacrylamide gels.

S. Udenfriend, K. Imai, P. Böhlen, 1974, Analytical biochemistry.

Homocarnosine in the cerebrospinal fluid of patients with Huntington's disease

G. Chazot, P. Schechter, P. Böhlen, 1980, Brain Research Bulletin.

The effect of γ-vinyl GABA and γ-acetylenic GABA on the concentration of homocarnosine in brain and CSF of the rat

M. Palfreyman, P. Böhlen, S. Huot, 1980, Brain Research.

Treatment of Huntington disease with γ ‐acetylenic GABA, an irreversible inhibitor of GABA‐ transaminase

Y. Agid, A. Bonnet, G. Chazot, 1981, Neurology.

Monoclonal antibodies targeting the VEGF receptor-2 (Flk1/KDR) as an anti-angiogenic therapeutic strategy

D. Hicklin, Zhen-ping Zhu, B. Pytowski, 1998, Cancer and Metastasis Reviews.

Analysis of vasopressin gene expression by in situ hybridization and immunohistochemistry in semi-thin sections.

B. Bloch, P. Böhlen, A. -. Guitteny, 1988, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Amino acid sequence of human acidic fibroblast growth factor.

P. Böhlen, T. Müller, P. Gautschi-Sova, 1986, Biochemical and biophysical research communications.

Partial molecular characterization of endothelial cell mitogens from human brain: acidic and basic fibroblast growth factors

P. Böhlen, M. Fràter-schröder, Peter Gautschi, 1986, FEBS letters.

The effect of 4-amino hex-5-ynoic acid (gamma-acetylenic GABA, gammma-ethynyl GABA) a catalytic inhibitor of GABA transaminase, on brain GABA metabolism in vivo.

A. Sjoerdsma, P. Schechter, B. Metcalf, 1977, Journal of neurochemistry.

The effect of gamma-vinyl GABA and gamma-acetylenic GABA on the concentration of homocarnosine in brain and CSF of the rat.

M. Palfreyman, P. Böhlen, S. Huot, 1980, Brain research.

Partial amino acid sequence of a somatostatin receptor isolated from GH4C1 pituitary cells.

P. Böhlen, J. Hulmes, J. Zysk, 1992, Biochemical and biophysical research communications.

The relationship between GABA concentrations in brain and cerebrospinal fluid

M. Palfreyman, P. Böhlen, S. Huot, 1979, Brain Research Bulletin.

[Polyamines in psoriasis].

P. Schechter, J. Koch-weser, P. Böhlen, 1980, Annales de dermatologie et de venereologie.

Skin polyamine levels in psoriasis: the effect of dithranol therapy *

J. Koch-weser, P. Böhlen, E. Grosshans, 1978, European journal of clinical investigation.

Genomic organization of the human HBNF gene and characterization of an HBNF variant protein as a splice mutant.

I. Kovesdi, P. Kretschmer, J. Fairhurst, 1993, Biochemical and biophysical research communications.

Radioimmunoassay for fibroblast growth factor (FGF): release by the bovine anterior pituitary in vitro

N. Ling, R. Guillemin, A. Baird, 1985, Regulatory Peptides.

Reverse-phase high-performance liquid chromatography of proteins: the separation of hemoglobin chain variants.

P. Petrides, R. Jones, P. Böhlen, 1980, Analytical Biochemistry.

Isolation and characterization of epidermal growth factor from human milk

E. Shooter, P. Petrides, P. Böhlen, 1985, FEBS letters.

Analysis for imino acids with o-phthalaldehyde.

P. Böhlen, 1983, Methods in enzymology.

Isolation and characterization of caprine corticotropin-releasing factor.

N. Ling, R. Guillemin, A. Baird, 1984, Biochemical and biophysical research communications.

Basic Fibroblast Growth Factor in the Adrenal Gland

K. Unsicker, C. Grothe, D. Blottner, 1989, The European journal of neuroscience.

Growth hormone-releasing factor from ovine and caprine hypothalamus: isolation, sequence analysis and total synthesis.

N. Ling, R. Guillemin, W. B. Wehrenberg, 1984, Biochemical and biophysical research communications.

Growth Hormone-Releasing Factor: Chemistry and Physiology

N. Ling, R. Guillemin, B. Bloch, 1984, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Purification of peptides: an efficient procedure for the separation of peptides from amino acids and salt.

N. Ling, R. Guillemin, P. Böhlen, 2009, International journal of peptide and protein research.

Isolation and Characterization of Opioid Peptides from Rabbit Cerebellum

J. Madden, C. Evans, A. Tyler, 1991, Journal of Neurochemistry.

Refolding and characterization of human recombinant heparin-binding neurite-promoting factor.

I. Kovesdi, J. Backer, J. Fairhurst, 1994, Protein expression and purification.

Rat hypothalamic growth hormone-releasing factor: isolation, sequence analysis and total synthesis.

N. Ling, R. Guillemin, W. B. Wehrenberg, 1984, Biochemical and biophysical research communications.

Chemical and biological characterization of a truncated form of acidic fibroblast growth factor from bovine brain.

P. Böhlen, T. Müller, P. Gautschi, 1986, European journal of biochemistry.

Structure/Activity Relationships in Basic FGF

I. Kovesdi, Y. Gluzman, P. Böhlen, 1991, Annals of the New York Academy of Sciences.

Development of a High Throughput Screening Assay for Inhibitors of Fibroblast Growth Factor-Receptor-Heparin Interactions

A. Yayon, M. Wildey, D. Aviezer, 2001, Journal of biomolecular screening.

1H, 15N, 13C and 13CO assignments and secondary structure determination of basic fibroblast growth factor using 3D heteronuclear NMR spectroscopy

E. Campbell, R. Powers, F. Moy, 1995, Journal of biomolecular NMR.

Engineering of fibroblast growth factor: alteration of receptor binding specificity.

A. Yayon, D. Aviezer, P. Böhlen, 1995, Biochemistry.

Development of a High Throughput Screening Assay for Inhibitors of Fibroblast Growth Factor-Receptor-Heparin Interactions

A. Yayon, M. Wildey, D. Aviezer, 2001, Journal of biomolecular screening.

The effect of γ-vinyl GABA and γ-acetylenic GABA on the concentration of homocarnosine in brain and CSF of the rat

M. Palfreyman, P. Böhlen, S. Huot, 1980, Brain Research.

FREE GABA, GABA CONJUGATES AND HOMOCARNOSINE IN CSF: RELATIONSHIP TO BRAIN GABA

P. Schechter, M. Palfreyman, P. Böhlen, 1980 .

GABA and homocarnosine in CSF: The relationship to brain GABA content

M. Palfreyman, P. Böhlen, S. Huot, 1980, Brain Research Bulletin.